NANETS Monthly Virtual Programming Series: NANETS & SNMMI: Radioligand Therapy and Treatment Sequencing for Metastatic and Unresectable Pheochromocytomas and Paragangliomas

 Registration is closed for this event

Home

NANETS Monthly Virtual Programming Series: NANETS/SNMMI: Radioligand Therapy and Treatment Sequencing for Metastatic and Unresectable Pheochromocytomas and Paragangliomas

Wednesday, August 18, 2021, 6:00-7:00pm EDT via Zoom

Presented in collaboration by the Society of Nuclear Medicine and Molecular Imaging (SNMMI)


Program

Radioligand therapy, which delivers radiation to specifically targeted cancer cells, has been shown to improve quality of life and perhaps survival for many people with neuroendocrine cancers. This case-based session will explore where in the patients’ journey it is most appropriate to consider the use ofmIBG therapy, in the context of other available and standard therapies for metastatic and unresectable pheochromocytomas and paragangliomas. We will review the role of functional imaging as well as the importance of peri-treatment blockade.

Speakers

Oncologist Perspective: Jaydira Del Rivero, MD, Assistant Research Physician, National Cancer Institute

Endocrinologist Perspective: Camilo Jimenez, MD, Professor, University of Texas MD Anderson Cancer Center

Nuclear Medicine Physician Perspective: Neeta Pandit-Taskar, MD, Nuclear Medicine Physician, Memorial Sloan Kettering

Moderated by Lisa Bodei, MD, PhD, Memorial Sloan Kettering


This event is free and open to anyone interested.

Not a member?

Read more about NANETS Membership here

Read more about SNMMI Membership here

 

When
August 18, 2021 6:00 PM through  7:00 PM
Location
Zoom
United States
Contact
Phone: 650-762-6387